河南东吉高科有限公司
标准物质
| CNLM-11113-MG-PK | -Acetyl–(3-hydroxypropyl)-L-cysteine (cysteine-¹³C₃, 99%; acetyl-1-¹³C, 99%; ¹⁵N,99%) | - |
| CNLM-11113-PK | -Acetyl–(3-hydroxypropyl)-L-cysteine (cysteine-¹³C₃, 99%; acetyl-1-¹³C, 99%; ¹⁵N,99%) | - |
| CNLM-11115-PK | -Acetyl–(2-carbamoyl-2-hydroxyethyl)-L-cysteine·HCl (cysteine-¹³C₃,99%; acetyl-1-¹³C,99%;¹⁵N,99%) | - |
| CNLM-11116-PK | -Acetyl–(3-hydroxypropyl-1-methyl)-L-cysteine (cysteine-¹³C₃, 99%; acetyl-1-¹³C, 99%; ¹⁵N,99%) | - |
| CNLM-11120-PK | 2′–Methyladenosine (¹³C₁₀, 98%; ¹⁵N₅, 96-98%) | - |
| CNLM-11344-CA | Pseudouridine 5′-monophosphate, ammonium salt (¹³C₉, 99%; ¹⁵N₂, 98%) (in solution) | - |
| CNLM-11345-CA | Pseudouridine, hydrate (¹³C₉, 99%; ¹⁵N₂, 98%) (in solution) | - |
| CNLM-11465-1.2 | Icaridin (piperidinyl-2,6-¹³C₂, 99%; ¹⁵N, 98%) 100 µg/mL in acetonitrile | - |
| CNLM-11595-1.2 | Nicotelline (2,4-dipyridyl-2,2’,6,6’-¹³C₄, 99%; 2,4-dipyridyl-¹⁵N₂, 98%) 100 µg/mL in acetonitirile | - |
| CNLM-11613-SL-10 | Adenosine phosphoramidite (U-¹³C₁₀, 98%; U-¹⁵N₅, 98%) CP 95% | - |
| CNLM-11613-SL-50 | Adenosine phosphoramidite (U-¹³C₁₀, 98%; U-¹⁵N₅, 98%) CP 95% | - |
| CNLM-11614-SL-10 | Cytidine phosphoramidite (U-¹³C₉, 98%; U-¹⁵N₃, 98%) CP 95% | - |
| CNLM-11614-SL-50 | Cytidine phosphoramidite (U-¹³C₉, 98%; U-¹⁵N₃, 98%) CP 95% | - |
| CNLM-11615-SL-10 | Guanosine phosphoramidite (U-¹³C₁₀, 98%; U-¹⁵N₅, 98%) CP 95% | - |
| CNLM-11615-SL-50 | Guanosine phosphoramidite (U-¹³C₁₀, 98%; U-¹⁵N₅, 98%) CP 95% | - |
| CNLM-11616-SL-10 | Uridine phosphoramidite (U-¹³C₉, 98%; U-¹⁵N₂, 98%) CP 95% | - |
| CNLM-11616-SL-50 | Uridine phosphoramidite (U-¹³C₉, 98%; U-¹⁵N₂, 98%) CP 95% | - |
| CNLM-11665-1MG | L-Carnitine∙HCl, -decanoyl (trimethyl-¹³C₃, 98%; ¹⁵N, 98%) CP 95% | - |
| CNLM-11739-CA | Pseudouridine 5′-triphosphate, ammonium salt (¹³C₉, 99%; ¹⁵N₂, 98%) (in solution) CP 95% | - |
| CNLM-1275-H-0.1 | L-GLUTAMINE | 0.1G |
| CNLM-1275-H-0.25 | L-GLUTAMINE | 0.25G |
| CNLM-1275-H-0.5 | L-GLUTAMINE | 0.5G |
| CNLM-1673-H-0.25 | GLYCINE | 0.25G |
| CNLM-1673-H-0.5 | GLYCINE | 0.5G |
| CNLM-1673-H-1 | GLYCINE | 1G |
| CNLM-1673-H-MPT | Glycine (¹³C₂, 99%; ¹⁵N, 99%) microbiological/pyrogen tested | - |
| CNLM-1825-0.25 | FORMAMIDE | 0.25G |
| CNLM-1961-0.5 | Potassium cyanide (¹³C, 99%; ¹⁵N, 98%) | - |
| CNLM-1961-1 | Potassium cyanide (¹³C, 99%; ¹⁵N, 98%) | - |
| CNLM-1961-PK | Potassium cyanide (¹³C, 99%; ¹⁵N, 98%) | - |
| CNLM-234-0.5 | UREA | 0.5G |
| CNLM-2392-0.05 | L-ASPARTIC ACID-N-T-BOC, B-BZ ESTER | 0.05G |
| CNLM-2393-0.05 | L-PHENYLALANINE-N-T-BOC | 0.05G |
| CNLM-2394-0.05 | L-ALANINE-N-T-BOC | 0.05G |
| CNLM-2394-0.1 | L-ALANINE-N-T-BOC | 0.1G |
| CNLM-2395-0.05 | L-VALINE-N-T-BOC | 0.05G |
| CNLM-2396-0.05 | L-LEUCINE-N-T-BOC:H2O | 0.05G |
| CNLM-2408-1 | GFL PEPTIDE STANDARD | 1STANDARD |
| CNLM-2412-0.1 | GLYCINE-N-T-BOC | 0.1G |
| CNLM-2475-H-0.1 | L-TRYPTOPHAN | 0.1G |
| CNLM-281-H-0.05 | L-LEUCINE | 0.05G |
| CNLM-281-H-0.1 | L-LEUCINE | 0.1G |
| CNLM-281-H-0.25 | L-LEUCINE | 0.25G |
| CNLM-291-H-0.05 | L-LYSINE:2HCL | 0.05G |
| CNLM-291-H-0.1 | L-LYSINE:2HCL | 0.1G |
| CNLM-291-H-0.1MG | L-LYSINE:2HCL | 0.1MG |
| CNLM-291-H-0.25 | L-LYSINE:2HCL | 0.25G |
| CNLM-291-H-0.5 | L-LYSINE:2HCL | 0.5G |
| CNLM-291-H-1 | L-LYSINE:2HCL | 1G |
| CNLM-3003-0.25 | POTASSIUM CYANATE | 0.25G |
| CNLM-333-0.1 | CAFFEINE | 0.1G |
| CNLM-3440-PK | β-Alanine (3-¹³C, 99%; ¹⁵N, 98%) | - |
| CNLM-3445-PK | Dopamine (2-(3,4-dihydroxyphenyl)-ethylamine)·HCl (1-¹³C, 99%; ¹⁵N, 99%) | - |
| CNLM-3446-PK | Ethylenediamine·2HCl (¹³C₂, 99%; ¹⁵N₂, 99%) | - |
| CNLM-3450-0.5 | L-LEUCINE | 0.5G |
| CNLM-3453-0.1 | DL-LYSINE:2HCL | 0.1G |
| CNLM-3454-PK | L-Lysine·2HCl (6-¹³C, 99%; ε-¹⁵N, 98%) | - |
| CNLM-3466-0.25 | L-VALINE | 0.25G |
| CNLM-3594-0.25 | L-ALANINE | 0.25G |
| CNLM-3643-S | 2,4,6-TRINITROTOLUENE WETTED,1 MG (TNT)/ML IN C6H6 | 1ML |
| CNLM-3726-1 | ACETAMINOPHEN | 1G |
| CNLM-3726-1.2 | ACETAMINOPHEN | 1.2ML |
| CNLM-3752-25 | Fapyadenine (formyl-¹³C, 98%; Diamino-¹⁵N₂, 98%) | - |
| CNLM-3802-CA-10 | Adenosine 5′-monophosphate, ammonium salt (U-¹³C₁₀, 99%; U-¹⁵N₅, 98%) CP 95% (in solution) | - |
| CNLM-3802-CA-50 | Adenosine 5′-monophosphate, ammonium salt (U-¹³C₁₀, 99%; U-¹⁵N₅, 98%) CP 95% (in solution) | - |
| CNLM-3802-SL-10 | Adenosine 5′-monophosphate, lithium salt (U-¹³C₁₀, 98%; U-¹⁵N₅, 96%) (in solution) CP 95% | - |
| CNLM-3802-SL-50 | Adenosine 5′-monophosphate, lithium salt (U-¹³C₁₀, 98%; U-¹⁵N₅, 96%) (in solution) CP 95% | - |
| CNLM-3806-CA-10 | ADENOSINE | 10MG |
| CNLM-3806-CA-50 | ADENOSINE | 50MG |
| CNLM-3807-50 | CYTIDINE | 50MG |
| CNLM-3808-CA-10 | GUANOSINE:H2O | 10MG |
| CNLM-3808-CA-25 | GUANOSINE:H2O | 25MG |
| CNLM-3808-CA-5 | GUANOSINE:H2O | 5MG |
| CNLM-3809-CA | URIDINE:H2O | 100UMOL |
| CNLM-3809-CA-10 | URIDINE:H2O | 10MG |
| CNLM-3809-CA-5 | URIDINE:H2O | 5MG |
| CNLM-3809-CA-MG-PK | Uridine·H₂O (¹³C₉, 98%; ¹⁵N₂, 96-98%) CP 95% | - |
| CNLM-3809-CA-PK | Uridine·H₂O (¹³C₉, 98%; ¹⁵N₂, 96-98%) CP 95% | - |
| CNLM-3819-H-0.1 | L-ASPARAGINE:H2O | 0.1G |
| CNLM-3819-H-0.25 | L-ASPARAGINE:H2O | 0.25G |
| CNLM-3819-H-0.5 | L-ASPARAGINE:H2O | 0.5G |
| CNLM-3871-H-0.1 | L-CYSTEINE | 0.1G |
| CNLM-3871-H-0.25 | L-CYSTEINE | 0.25G |
| CNLM-3871-H-MG-PK | L-Cysteine (¹³C₃, 99%; ¹⁵N, 99%) | - |
| CNLM-3896-CA-10 | 2′-DEOXYADENOSINE MONOHYDRATE | 10MG |
| CNLM-3896-CA-25 | 2′-DEOXYADENOSINE MONOHYDRATE | 25MG |
| CNLM-3896-CA-5 | 2′-DEOXYADENOSINE MONOHYDRATE | 5MG |
| CNLM-3900-CA-10 | 2′-DEOXYGUANOSINE:H2O | 10MG |
| CNLM-3900-CA-25 | 2′-DEOXYGUANOSINE:H2O | 25MG |
| CNLM-3900-CA-5 | 2′-DEOXYGUANOSINE:H2O | 5MG |
| CNLM-3902-MG-PK | Thymidine (¹³C₁₀, 98%; ¹⁵N₂, 96-98%) | - |
| CNLM-3902-PK | Thymidine (¹³C₁₀, 98%; ¹⁵N₂, 96-98%) | - |
| CNLM-3916-0.01 | 5-FLUOROURACIL | 10MG |
| CNLM-3917-0.1 | URACIL | 0.1G |
| CNLM-3917-MG-PK | Uracil (¹³C₄, 99%; ¹⁵N₂, 98%) | - |
| CNLM-3918-SL-10 | 2′-Deoxyadenosine 5′-monophosphate (U-¹³C₁₀, 98%;U-¹⁵N₅, 98%) dilithium salt | - |
| CNLM-3918-SL-50 | 2′-Deoxyadenosine 5′-monophosphate (U-¹³C₁₀, 98%;U-¹⁵N₅, 98%) dilithium salt | - |
| CNLM-3924-SL-10 | Thymidine 5′-monophosphate, lithium salt (U-¹³C₁₀, 98%; U-¹⁵N₂, 98%) (in solution) CP 95% | - |
| CNLM-3924-SL-50 | Thymidine 5′-monophosphate, lithium salt (U-¹³C₁₀, 98%; U-¹⁵N₂, 98%) (in solution) CP 95% | - |
| CNLM-3946-0.25 | BETA-ALANINE | 0.25G |